In the Wake of Cannabis Export Approval, Medical Cannabis Experts from Science & Business to Gather at CannaTech Tel Aviv 2019 Add Comment
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program Add Comment